Abstract
Saturated fatty acids (SFAs) have been linked to cardiovascular disease complications. However, SFAs represent significant components of both enteral/parenteral nutritional formulations, which may further contribute to existing disease pathologies. The objective of the present study was to investigate whether oleic acid (C18:1) reduces the growth inhibitory and pro‐inflammatory effects of stearic acid (C18:0) in human aortic endothelial cells (HAECs). Growth and cytotoxicity assays were quantified by a WST‐1 assay. Adhesion molecule (ICAM‐1) expression and apoptosis was quantified by flow cytometry. NF‐κB activation was assayed by western blot. A lower concentration of stearic acid treatment inhibited cell proliferation, whereas a higher concentration induced cellular toxicity through an apoptotic mechanism. Stearic acid‐induced effects on cell proliferation and apoptosis were reduced by oleic acid in a dose dependent manner (0–25 μM). Stearic acid treatment also increased ICAM‐1 expression, which was also reduced by levels of oleic acid as low as 5 μM. Further, stearic acid activated NF‐κB a pro‐inflammatory mediator, in a dose dependent manner. However, when combined with oleic acid, this activation was reduced. Our data suggests that oleic acid has the ability to reduce the growth inhibitory and pro‐inflammatory effects of long‐chain saturated fatty acids, specifically stearic acid, on HAECs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.